Atlas FDA

QHA

7 FDA 510(k) clearances · Product code

239 daysmedian time to decision
265 days90th percentile
7clearances measured

FDA profile

Official device name
X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
Device class
Class II (moderate risk)
Regulation
21 CFR 892.1600
Medical specialty
Radiology
FDA definition
X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
X1-FFR (K251355)Spectrawave, Inc.2025-10-17
QFR (3.0) (K243769)Qfr Solutions BV2025-04-04
CAAS Workstation (K232147)Pie Medical Imaging BV2024-04-09
AccuFFRangio Plus (K230303)ArteryFlow Technology Co., Ltd.2023-03-02
AccuICAS (K221711)ArteryFlow Technology Co., Ltd.2023-02-28
AccuFFRangio (K210093)ArteryFlow Technology Co., Ltd.2021-09-10
Qangio XA 3D (K182611)Medis Medical Imaging Systems BV2019-05-30

Track QHA automatically

Every clearance here is in the API, with alerts when new ones post.